|
시장보고서
상품코드
1872276
세계의 대사체학 시약 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)Metabolomics Reagents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 |
||||||
QYResearch
세계의 대사체학 시약 시장 규모는 2024년에 2,940만 달러로 추정되며, 2025년부터 2031년까지 예측 기간 동안 CAGR 13.2%로 성장하여 2031년까지 6,980만 달러로 확대될 것으로 예측됩니다.
대사체학 시약은 생물학적 시스템 내의 대사산물(저분자 화합물)을 검출, 정량, 분석하기 위해 대사체학 조사에서 사용되는 특수 화학제품, 화합물 또는 물질을 말합니다. 대사체학은 생물학적 활동 중에 생체 내에서 생성되는 다양한 대사물질을 종합적으로 검출하고 분석하기 위해 사용되는 일련의 기술을 말합니다. 대사물의 질적, 양적 변화는 끊임없이 변화하는 생물학적 현상을 반영하여 진단, 바이오마커 발굴, 신약개발 연구에 폭넓게 활용되고 있습니다. 최근에는 식품 산업에서 맛과 품질 향상, 기능성 식품 개발에 활용되고 있으며, 생명공학 산업에서는 발효 및 바이오연료의 생산성 향상에도 활용되고 있습니다.
정밀의료는 유전자, 환경, 생활습관 등 개인차를 기반으로 한 개인별 맞춤 치료를 목표로 합니다. 대사체 분석은 질병 특이적 바이오마커를 찾아내어 개인별 맞춤 치료 계획을 수립하는 데 중요한 역할을 합니다. 이러한 추세로 인해 임상 연구 및 진단 응용 분야에서의 시약 수요가 가속화되고 있습니다.
제약사들은 약물 대사, 효능, 독성을 더 깊이 이해하기 위해 대사체학을 활용하고 있습니다. 의약품 개발자들이 약물의 안전성과 유효성 프로파일을 개선하기 위해 전임상 및 임상 단계에 대사체학을 통합함에 따라 대사체학 시약에 대한 수요가 증가하고 있습니다.
질량분석(MS)과 핵자기공명(NMR)은 대사체학에서 사용되는 주요 분석 기술입니다. 감도 향상, 고해상도화 등 이러한 기술의 발전으로 인해 고품질 시약의 필요성이 높아지고 있습니다. 시약 시장은 임상 실험실 및 연구 기관에서 이러한 플랫폼의 채택이 확대됨에 따라 혜택을 누리고 있습니다.
대사체학은 유전체학, 단백질체학, 전사체학 등과 결합하여 생물학적 시스템에 대한 보다 종합적인 이해를 제공하고 있습니다. 이러한 멀티오믹스 접근 방식은 서로 다른 플랫폼에서 작동하고 연구마다 일관된 결과를 제공할 수 있는 시약에 대한 필요성을 불러일으켰습니다.
질량분석(MS), 핵자기공명(NMR)과 같은 첨단 대사체학 플랫폼의 도입 및 유지비용은 매우 비쌉니다. 이러한 시스템에 사용되는 시약도 특히 고순도 및 특수 시약을 사용하는 경우 고가의 시약이 사용되는 경향이 있습니다. 이러한 높은 비용으로 인해 대사체학 도구의 이용은 자금력이 있는 대형 연구기관, 제약회사, 임상실험실에 국한되어 소규모 연구소나 신흥 시장에서의 가능성을 제한하고 있습니다.
실험실 간 표준화된 프로토콜과 시약이 부족하여 서로 다른 연구 결과의 비교가 어렵습니다. 시약, 기기 교정, 실험 설계의 편차는 결과의 불일치를 초래하고, 대사체학 데이터의 신뢰성을 떨어뜨립니다. 이러한 불일치는 임상 진단 및 대규모 연구에서 신뢰할 수 있는 도구로서 대사체학을 확립하려는 노력을 방해하고 있습니다.
이 보고서는 대사체학 시약 세계 시장에 대한 종합적인 분석을 제공하는 것을 목표로 합니다. 총 매출액, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고, 지역별, 국가별, 유형별, 용도별 대사체학 시약 분석을 포함하고 있습니다.
대사체학 시약 시장의 규모, 추정 및 예측은 2024년을 기준 연도로 하여 2020년에서 2031년까지의 과거 데이터와 예측 데이터를 포함하는 매출 수익으로 제시되었습니다. 정량적, 정성적 분석을 통해 독자들이 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 자사 포지셔닝 분석, 대사체 분석 시약에 대한 정보에 입각한 비즈니스 의사결정을 할 수 있도록 지원합니다.
시장 세분화
기업별
- Cambridge Isotope Laboratories
- Biocrates
- IROA Technologies
- Fluidome
- Metabolomix
- Beijing BGI-GBI Biotech Co., Ltd.(GBI)
- Metware Biotechnology
- BIOTERE
유형별 부문
- 표적 대사체학
- 비표적 대사체학
용도별 부문
- 바이오 관련 기업
- 조사기관
- 교육기관
지역별
- 북미
- 미국
- 캐나다
- 아시아태평양
- 중국
- 일본
- 한국
- 동남아시아
- 인도
- 호주
- 기타 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 네덜란드
- 북유럽 국가
- 기타 유럽
- 라틴아메리카
- 멕시코
- 브라질
- 기타 라틴아메리카
- 중동 및 아프리카
- 튀르키예
- 사우디아라비아
- 아랍에미리트
- 기타 중동 및 아프리카
자주 묻는 질문
The global market for Metabolomics Reagents was estimated to be worth US$ 29.4 million in 2024 and is forecast to a readjusted size of US$ 69.8 million by 2031 with a CAGR of 13.2% during the forecast period 2025-2031.
Metabolomics reagents are specialized chemicals, compounds, or materials used in metabolomics research to detect, quantify, and analyse metabolites (small molecules) within biological systems. Metabolomics refers to an array of techniques used to comprehensively detect and analyse various metabolites formed in vivo during biological activity. The qualitative and quantitative changes in metabolites reflect the ever-changing biological phenomena and are widely used for diagnosis, biomarker discovery, and drug discovery research. In recent years, metabolomics has been used in the food industry to improve taste and quality and to develop functional foods. It is also used in the biotechnology industry to improve fermentation and biofuel productivity.
Precision medicine aims to tailor treatments based on individual variability in genes, environment, and lifestyle. Metabolomics plays a critical role in identifying disease-specific biomarkers, leading to personalized treatment plans. This trend is accelerating the demand for reagents in clinical research and diagnostic applications.
Pharmaceutical companies are leveraging metabolomics to better understand drug metabolism, efficacy, and toxicity. The demand for metabolomics reagents is rising as drug developers integrate metabolomics into preclinical and clinical phases to improve drug safety and efficacy profiles.
MS and NMR are key analytical techniques used in metabolomics. Advancements in these technologies, such as increased sensitivity and higher resolution, are driving the need for high-quality reagents. The reagents market is benefitting from the growing adoption of these platforms in clinical labs and research institutions.
Metabolomics is increasingly being combined with genomics, proteomics, and transcriptomics to provide a more comprehensive understanding of biological systems. This multi-omics approach is creating a need for reagents that can function across different platforms and deliver consistent results across studies.
The cost of acquiring and maintaining advanced metabolomics platforms, such as mass spectrometry (MS) and nuclear magnetic resonance (NMR), is very high. The reagents used in these systems are often expensive as well, especially when using high-purity, specialized reagents. This high cost limits the accessibility of metabolomics tools to large, well-funded research institutions, pharmaceutical companies, and clinical labs, reducing its potential in smaller labs and emerging markets.
There is a lack of standardized protocols and reagents across laboratories, which makes it difficult to compare results from different studies. Variability in reagents, instrument calibration, and experimental design can lead to inconsistent results, reducing confidence in metabolomics data. This inconsistency hampers efforts to establish metabolomics as a reliable tool in clinical diagnostics and large-scale studies.
This report aims to provide a comprehensive presentation of the global market for Metabolomics Reagents, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Metabolomics Reagents by region & country, by Type, and by Application.
The Metabolomics Reagents market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabolomics Reagents.
Market Segmentation
By Company
- Cambridge Isotope Laboratories
- Biocrates
- IROA Technologies
- Fluidome
- Metabolomix
- Beijing BGI-GBI Biotech Co., Ltd. (GBI)
- Metware Biotechnology
- BIOTERE
Segment by Type
- Targeted Metabolomics
- Untargeted Metabolomics
Segment by Application
- Biological Companies
- Research Institutions
- Educational Institutions
By Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Metabolomics Reagents company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Metabolomics Reagents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Metabolomics Reagents in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
- 1.1 Metabolomics Reagents Product Introduction
- 1.2 Global Metabolomics Reagents Market Size Forecast (2020-2031)
- 1.3 Metabolomics Reagents Market Trends & Drivers
- 1.3.1 Metabolomics Reagents Industry Trends
- 1.3.2 Metabolomics Reagents Market Drivers & Opportunity
- 1.3.3 Metabolomics Reagents Market Challenges
- 1.3.4 Metabolomics Reagents Market Restraints
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Competitive Analysis by Company
- 2.1 Global Metabolomics Reagents Players Revenue Ranking (2024)
- 2.2 Global Metabolomics Reagents Revenue by Company (2020-2025)
- 2.3 Key Companies Metabolomics Reagents Manufacturing Base Distribution and Headquarters
- 2.4 Key Companies Metabolomics Reagents Product Offered
- 2.5 Key Companies Time to Begin Mass Production of Metabolomics Reagents
- 2.6 Metabolomics Reagents Market Competitive Analysis
- 2.6.1 Metabolomics Reagents Market Concentration Rate (2020-2025)
- 2.6.2 Global 5 and 10 Largest Companies by Metabolomics Reagents Revenue in 2024
- 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolomics Reagents as of 2024)
- 2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
- 3.1 Introduction by Type
- 3.1.1 Targeted Metabolomics
- 3.1.2 Untargeted Metabolomics
- 3.2 Global Metabolomics Reagents Sales Value by Type
- 3.2.1 Global Metabolomics Reagents Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global Metabolomics Reagents Sales Value, by Type (2020-2031)
- 3.2.3 Global Metabolomics Reagents Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
- 4.1 Introduction by Application
- 4.1.1 Biological Companies
- 4.1.2 Research Institutions
- 4.1.3 Educational Institutions
- 4.2 Global Metabolomics Reagents Sales Value by Application
- 4.2.1 Global Metabolomics Reagents Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global Metabolomics Reagents Sales Value, by Application (2020-2031)
- 4.2.3 Global Metabolomics Reagents Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
- 5.1 Global Metabolomics Reagents Sales Value by Region
- 5.1.1 Global Metabolomics Reagents Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global Metabolomics Reagents Sales Value by Region (2020-2025)
- 5.1.3 Global Metabolomics Reagents Sales Value by Region (2026-2031)
- 5.1.4 Global Metabolomics Reagents Sales Value by Region (%), (2020-2031)
- 5.2 North America
- 5.2.1 North America Metabolomics Reagents Sales Value, 2020-2031
- 5.2.2 North America Metabolomics Reagents Sales Value by Country (%), 2024 VS 2031
- 5.3 Europe
- 5.3.1 Europe Metabolomics Reagents Sales Value, 2020-2031
- 5.3.2 Europe Metabolomics Reagents Sales Value by Country (%), 2024 VS 2031
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Metabolomics Reagents Sales Value, 2020-2031
- 5.4.2 Asia Pacific Metabolomics Reagents Sales Value by Region (%), 2024 VS 2031
- 5.5 South America
- 5.5.1 South America Metabolomics Reagents Sales Value, 2020-2031
- 5.5.2 South America Metabolomics Reagents Sales Value by Country (%), 2024 VS 2031
- 5.6 Middle East & Africa
- 5.6.1 Middle East & Africa Metabolomics Reagents Sales Value, 2020-2031
- 5.6.2 Middle East & Africa Metabolomics Reagents Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
- 6.1 Key Countries/Regions Metabolomics Reagents Sales Value Growth Trends, 2020 VS 2024 VS 2031
- 6.2 Key Countries/Regions Metabolomics Reagents Sales Value, 2020-2031
- 6.3 United States
- 6.3.1 United States Metabolomics Reagents Sales Value, 2020-2031
- 6.3.2 United States Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States Metabolomics Reagents Sales Value by Application, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe Metabolomics Reagents Sales Value, 2020-2031
- 6.4.2 Europe Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe Metabolomics Reagents Sales Value by Application, 2024 VS 2031
- 6.5 China
- 6.5.1 China Metabolomics Reagents Sales Value, 2020-2031
- 6.5.2 China Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China Metabolomics Reagents Sales Value by Application, 2024 VS 2031
- 6.6 Japan
- 6.6.1 Japan Metabolomics Reagents Sales Value, 2020-2031
- 6.6.2 Japan Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan Metabolomics Reagents Sales Value by Application, 2024 VS 2031
- 6.7 South Korea
- 6.7.1 South Korea Metabolomics Reagents Sales Value, 2020-2031
- 6.7.2 South Korea Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea Metabolomics Reagents Sales Value by Application, 2024 VS 2031
- 6.8 Southeast Asia
- 6.8.1 Southeast Asia Metabolomics Reagents Sales Value, 2020-2031
- 6.8.2 Southeast Asia Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia Metabolomics Reagents Sales Value by Application, 2024 VS 2031
- 6.9 India
- 6.9.1 India Metabolomics Reagents Sales Value, 2020-2031
- 6.9.2 India Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India Metabolomics Reagents Sales Value by Application, 2024 VS 2031
7 Company Profiles
- 7.1 Cambridge Isotope Laboratories
- 7.1.1 Cambridge Isotope Laboratories Profile
- 7.1.2 Cambridge Isotope Laboratories Main Business
- 7.1.3 Cambridge Isotope Laboratories Metabolomics Reagents Products, Services and Solutions
- 7.1.4 Cambridge Isotope Laboratories Metabolomics Reagents Revenue (US$ Million) & (2020-2025)
- 7.1.5 Cambridge Isotope Laboratories Recent Developments
- 7.2 Biocrates
- 7.2.1 Biocrates Profile
- 7.2.2 Biocrates Main Business
- 7.2.3 Biocrates Metabolomics Reagents Products, Services and Solutions
- 7.2.4 Biocrates Metabolomics Reagents Revenue (US$ Million) & (2020-2025)
- 7.2.5 Biocrates Recent Developments
- 7.3 IROA Technologies
- 7.3.1 IROA Technologies Profile
- 7.3.2 IROA Technologies Main Business
- 7.3.3 IROA Technologies Metabolomics Reagents Products, Services and Solutions
- 7.3.4 IROA Technologies Metabolomics Reagents Revenue (US$ Million) & (2020-2025)
- 7.3.5 IROA Technologies Recent Developments
- 7.4 Fluidome
- 7.4.1 Fluidome Profile
- 7.4.2 Fluidome Main Business
- 7.4.3 Fluidome Metabolomics Reagents Products, Services and Solutions
- 7.4.4 Fluidome Metabolomics Reagents Revenue (US$ Million) & (2020-2025)
- 7.4.5 Fluidome Recent Developments
- 7.5 Metabolomix
- 7.5.1 Metabolomix Profile
- 7.5.2 Metabolomix Main Business
- 7.5.3 Metabolomix Metabolomics Reagents Products, Services and Solutions
- 7.5.4 Metabolomix Metabolomics Reagents Revenue (US$ Million) & (2020-2025)
- 7.5.5 Metabolomix Recent Developments
- 7.6 Beijing BGI-GBI Biotech Co., Ltd. (GBI)
- 7.6.1 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Profile
- 7.6.2 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Main Business
- 7.6.3 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Metabolomics Reagents Products, Services and Solutions
- 7.6.4 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Metabolomics Reagents Revenue (US$ Million) & (2020-2025)
- 7.6.5 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Recent Developments
- 7.7 Metware Biotechnology
- 7.7.1 Metware Biotechnology Profile
- 7.7.2 Metware Biotechnology Main Business
- 7.7.3 Metware Biotechnology Metabolomics Reagents Products, Services and Solutions
- 7.7.4 Metware Biotechnology Metabolomics Reagents Revenue (US$ Million) & (2020-2025)
- 7.7.5 Metware Biotechnology Recent Developments
- 7.8 BIOTERE
- 7.8.1 BIOTERE Profile
- 7.8.2 BIOTERE Main Business
- 7.8.3 BIOTERE Metabolomics Reagents Products, Services and Solutions
- 7.8.4 BIOTERE Metabolomics Reagents Revenue (US$ Million) & (2020-2025)
- 7.8.5 BIOTERE Recent Developments
8 Industry Chain Analysis
- 8.1 Metabolomics Reagents Industrial Chain
- 8.2 Metabolomics Reagents Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis (Customers Analysis)
- 8.5 Sales Model and Sales Channels
- 8.5.1 Metabolomics Reagents Sales Model
- 8.5.2 Sales Channel
- 8.5.3 Metabolomics Reagents Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.1.1 Research Programs/Design
- 10.1.1.2 Market Size Estimation
- 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
- 10.1.2.1 Secondary Sources
- 10.1.2.2 Primary Sources
- 10.1.1 Methodology/Research Approach
- 10.2 Author Details
- 10.3 Disclaimer
